Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy. Dermatol Reports [Internet]. 2025 Jul. 1 [cited 2025 Aug. 4];. Available from: https://journals.pagepress.org/dr/article/view/10315